Determinants of the tumor suppressor INPP4B protein and lipid phosphatase activities
Sandra M Lopez1, Myles C Hodgson, Charles Packianathan
1Department of Cell Biology and Pharmacology, Herbert Wertheim College of Medicine, Florida International University, 11200 SW 8th St. Miami, FL 33199, USA.
Abstract:
The tumor suppressor INPP4B is an important regulator of phosphatidyl-inositol signaling in the cell. Reduced INPP4B expression is associated with poor outcomes for breast, prostate, and ovarian cancer patients. INPP4B contains a CX5R catalytic motif characteristic of dual-specificity phosphatases, such as PTEN. Lipid phosphatase activity of INPP4B has previously been described. In this report we show that INPP4B can dephosphorylate para-nitrophenyl phosphate (pNPP) and 6,8-difluoro-4-methylumbelliferyl (DiFMUP), synthetic phosphotyrosine analogs, suggesting that INPP4B has protein tyrosine phosphatase (PTP) activity. Using mutagenesis, we examined the functional role of specific amino acids within the INPP4B C842KSAKDR catalytic site. The K843M mutant displayed increased pNPP hydrolysis, the K846M mutant lost lipid phosphatase activity with no effect on PTP activity, and the D847E substitution ablated PTP activity and significantly reduced lipid phosphatase activity. Further, we show that INPP4B but not PTEN is able to reduce tyrosine phosphorylation of Akt1 and both the lipid and PTP activity of INPP4B likely contribute to the reduction of Akt1 phosphorylation. Taken together our data identified key residues in the INPP4B catalytic domain associated with lipid and protein phosphatase activities and found a robust downstream target regulated by INPP4B but not PTEN.
Insights
The tumor suppressor INPP4B regulates cell signaling and has both lipid and protein tyrosine phosphatase (PTP) activities. Key catalytic residues were identified, revealing INPP4B regulates Akt1 phosphorylation, unlike PTEN.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- The INPP4B gene acts as a tumor suppressor, and its reduced expression correlates with poor prognoses in breast, prostate, and ovarian cancers.
- INPP4B possesses a catalytic motif common to dual-specificity phosphatases, similar to PTEN, and has known lipid phosphatase activity.
Purpose of the Study:
- To investigate the protein tyrosine phosphatase (PTP) activity of INPP4B.
- To identify key amino acid residues within the INPP4B catalytic domain responsible for its phosphatase activities.
- To determine downstream targets regulated by INPP4B.
Main Methods:
- Enzyme assays using synthetic substrates (pNPP, DiFMUP) to assess lipid and PTP activities.
- Site-directed mutagenesis of the INPP4B catalytic site (C842KSAKDR).
- Western blot analysis to detect Akt1 phosphorylation levels in the presence of INPP4B and PTEN.
Main Results:
- INPP4B demonstrated PTP activity by dephosphorylating synthetic phosphotyrosine analogs.
- Mutagenesis studies identified specific residues critical for lipid phosphatase (K846M) and PTP (D847E) activities.
- INPP4B, but not PTEN, reduced Akt1 tyrosine phosphorylation, indicating a unique downstream regulatory role.
Conclusions:
- This study elucidates the dual lipid and PTP enzymatic activities of INPP4B.
- Specific catalytic residues governing INPP4B's distinct functions were identified.
- INPP4B regulates Akt1 phosphorylation through both lipid and PTP activities, highlighting its unique role in cellular signaling pathways.
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Abnormal Proliferation
Inhibition of Cdk Activity
Inhibition of CDK Activity
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Intrinsic Apoptotic Pathway


